OUROFINO S/AON ED NMOUROFINO S/AON ED NMOUROFINO S/AON ED NM

OUROFINO S/AON ED NM

No trades
See on Supercharts

OFSA3 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Ourofino SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. It operates through the following segments: Production Animals, Companion Animals, and International Operations. The Production Animals segment focuses in the sale of domestic market of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses, and goats. The Companion Animals segment sell veterinary drugs and other products for dogs and cats. The International Operations offers veterinary drugs, vaccines, and products for production and companion animals in Latin American countries. The company was founded by Norival Bonamichi and Jardel Massari in 1987 and is headquartered in Cravinhos, Brazil.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
OFSA3 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company